text:
National Institute of Nursing Research (NINR)
Community Partnerships to Advance Research (CPAR) (R21 Clinical Trial Optional)
R21 Exploratory/Developmental Research Grant
Reissue of PA-14-141
March 10, 2020 - Reminder: FORMS-F Grant Application Forms & Instructions Must be Used for Due Dates On or After May 25, 2020- New Grant Application Instructions Now Available. See Notice NOT-OD-20-077.
November 26, 2018 - NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications. See Notice NOT-OD-18-228.
PA-18-381
PA-18-377, R01 Research Project Grant
PA-18-475, R15 Academic Research Enhancement Award (AREA)
This funding opportunity announcement (FOA) encourages researchers to partner with community groups, using Community Engaged Research (CEnR) methodologies that will enhance relationships and lead to better intervention development and positive health outcomes.
Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Standard dates apply
It is critical that applicants follow the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
Use the NIH ASSIST system to prepare, submit and track your application online.
Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.
Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.
Part 2. Full Text of the Announcement
The purpose of the funding opportunity is to stimulate researchers to partner with community groups, using Community Engaged Research (CEnR) methodologies that will enhance relationships and lead to better intervention development and positive health outcomes.
This funding opportunity announcement seeks to promote partnerships between researchers and community agencies, using Community Engaged Research (CEnR) methodologies. These partnerships are intended to enhance relationships in community settings, with the goal of producing better interventions. In turn, these enhanced interventions are expected to lead to positive health outcomes. Partnership is defined as an association of two or more persons or entities that conduct a study as equal co-investigators. Community Engagement (CE) lies on a continuum that reflects the level of involvement of community members, or representatives of community populations, in research. This continuum of involvement in research efforts ranges from community consent to research, to full participation and shared leadership of community members in research design and eventual dissemination and implementation. Advances in translating research findings into practice have been made; however, such advances have not been realized by all members of society according to age, race, ethnicity, and socioeconomic group. Narrowing the gap in translational research within the NINR strategic areas of emphasis is a priority for the Institute. Using CE approaches and addressing areas such as self and symptom management, health promotion and prevention is one way to narrow the gap. CE can take many forms, and partners can include community-based groups, agencies such as the Center for Medicare and Medicaid Services (CMS) Innovation Centers, Centers for Disease Control and Prevention (CDC) Prevention Research Centers, Health Resources and Services Administration (HRSA) Community Health Centers (CHC) and Federally Qualified Health Centers (FQHC), other academic health institutions, or individuals. Collaborators may be engaged in health promotion/prevention, clinical or intervention research.
An example NIH program, Partners in Research, was designed to improve public understanding of biomedical and behavioral science, develop strategies for promoting collaboration between scientists and the community to improve the health of the public, and to identify the conditions (e.g., settings and approaches) that enhance the effectiveness of such activities. This program announcement is modeled after approaches like Partners in Research and is intended to promote community partnerships in research, and to provide opportunities to build close collaborations between academic researchers and community members to generate better informed hypotheses, to develop more efficacious and effective interventions, and to enhance the translation of research results into practice. CEnR research methodologies are expected to result in more meaningful academic-community collaborations and relationships, which should also lead to sustainable interventions and improved health of individuals and communities. Investing in community and academic partnerships in research efforts will provide its greatest impact in translating established health care practices in health promotion and prevention and self and symptom management.
Responses to this announcement must identify researcher and community partnerships around well-defined health issues of mutual concern. Approaches proposed should incorporate information about sustaining health programs in community settings. Results of the partnership during the project period can include, but are not limited to:
Interventions/programs for health promotion/prevention
Interventions/programs leading to self-management of chronic conditions
Programs that target self or symptom management
Any intervention/program identified must also include measurement of explicit health outcomes. These health outcomes should emerge from mutual agreement among the researcher and community partners and, ideally, will be informed by available data about the local community environment.
By using the R21 mechanism, the NIH seeks to foster the introduction of novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. An R21 grant application needs not have extensive background material or preliminary information. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or, when available, from investigator-generated data.
Optional: Accepting applications that either propose or do not propose clinical trial(s)
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Eligible Agencies of the Federal Government
Non-domestic (non-U.S.) Entities (Foreign Institutions)
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).
It is critical that applicants follow the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
SF424(R&R) Other Project Information
SF424(R&R) Senior/Key Person Profile
R&R or Modular Budget
R&R Subaward Budget
Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide, with the following modification:
All applications, regardless of the amount of direct costs requested for any one year, should address a Data Sharing Plan.
Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
Use only for applications with due dates on or after January 25, 2018. When involving NIH-defined human subjects research, clinical research, and/or clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:
All instructions in the SF424 (R&R) Application Guide must be followed with the following additional instructions:
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH's electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.
Important Update: See NOT-OD-18-228 for updated review language for due dates on or after January 25, 2019.
Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.
A proposed Clinical Trial application may include study design, methods, and intervention that are not by themselves innovative but address important questions or unmet needs. Additionally, the results of the clinical trial may indicate that further clinical development of the intervention is unwarranted or lead to new avenues of scientific investigation.
The R21 exploratory/developmental grant supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information. Accordingly, reviewers will emphasize the conceptual framework, the level of innovation, and the potential to significantly advance our knowledge or understanding. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or, when available, from investigator-generated data. Preliminary data are not required for R21 applications; however, they may be included if available.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important problem or a critical barrier to progress in the field? Is there a strong scientific premise for the project? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
In addition, for applications proposing clinical trials
Are the scientific rationale and need for a clinical trial to test the proposed hypothesis or intervention well supported by preliminary data, clinical and/or preclinical studies, or information in the literature or knowledge of biological mechanisms? For trials focusing on clinical or public health endpoints, is this clinical trial necessary for testing the safety, efficacy or effectiveness of an intervention that could lead to a change in clinical practice, community behaviors or health care policy? For trials focusing on mechanistic, behavioral, physiological, biochemical, or other biomedical endpoints, is this trial needed to advance scientific understanding?
Investigator(s)
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or those in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
With regard to the proposed leadership for the project, do the PD/PI(s) and key personnel have the expertise, experience, and ability to organize, manage and implement the proposed clinical trial and meet milestones and timelines? Do they have appropriate expertise in study coordination, data management and statistics? For a multicenter trial, is the organizational structure appropriate and does the application identify a core of potential center investigators and staffing for a coordinating center?
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Does the design/research plan include innovative elements, as appropriate, that enhance its sensitivity, potential for information or potential to advance scientific knowledge or clinical practice?
Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?
If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of children, justified in terms of the scientific goals and research strategy proposed?
Does the application adequately address the following, if applicable
Is the study design justified and appropriate to address primary and secondary outcome variable(s)/endpoints that will be clear, informative and relevant to the hypothesis being tested? Is the scientific rationale/premise of the study based on previously well-designed preclinical and/or clinical research? Given the methods used to assign participants and deliver interventions, is the study design adequately powered to answer the research question(s), test the proposed hypothesis/hypotheses, and provide interpretable results? Is the trial appropriately designed to conduct the research efficiently? Are the study populations (size, gender, age, demographic group), proposed intervention arms/dose, and duration of the trial, appropriate and well justified?
Are potential ethical issues adequately addressed? Is the process for obtaining informed consent or assent appropriate? Is the eligible population available? Are the plans for recruitment outreach, enrollment, retention, handling dropouts, missed visits, and losses to follow-up appropriate to ensure robust data collection? Are the planned recruitment timelines feasible and is the plan to monitor accrual adequate? Has the need for randomization (or not), masking (if appropriate), controls, and inclusion/exclusion criteria been addressed? Are differences addressed, if applicable, in the intervention effect due to sex/gender and race/ethnicity?
Are the plans to standardize, assure quality of, and monitor adherence to, the trial protocol and data collection or distribution guidelines appropriate? Is there a plan to obtain required study agent(s)? Does the application propose to use existing available resources, as applicable?
Data Management and Statistical Analysis
Are planned analyses and statistical approach appropriate for the proposed study design and methods used to assign participants and deliver interventions? Are the procedures for data management and quality control of data adequate at clinical site(s) or at center laboratories, as applicable? Have the methods for standardization of procedures for data management to assess the effect of the intervention and quality control been addressed? Is there a plan to complete data analysis within the proposed period of the award?
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
If proposed, are the administrative, data coordinating, enrollment and laboratory/testing centers, appropriate for the trial proposed?
Does the application adequately address the capability and ability to conduct the trial at the proposed site(s) or centers? Are the plans to add or drop enrollment centers, as needed, appropriate?
If international site(s) is/are proposed, does the application adequately address the complexity of executing the clinical trial?
If multi-sites/centers, is there evidence of the ability of the individual site or center to: (1) enroll the proposed numbers; (2) adhere to the protocol; (3) collect and transmit data in an accurate and timely fashion; and, (4) operate within the proposed organizational structure?
Study Timeline
Specific to applications proposing clinical trials
Is the study timeline described in detail, taking into account start-up activities, the anticipated rate of enrollment, and planned follow-up assessment? Is the projected timeline feasible and well justified? Does the project incorporate efficiencies and utilize existing resources (e.g., CTSAs, practice-based research networks, electronic medical records, administrative database, or patient registries) to increase the efficiency of participant enrollment and data collection, as appropriate?
Are potential challenges and corresponding solutions discussed (e.g., strategies that can be implemented in the event of enrollment shortfalls)?
For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.
Inclusion of Women, Minorities, and Children
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of children to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
Applications from Foreign Organizations
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s)convened by the Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications. Following initial peer review, recommended applications will receive a second level of review by the appropriate national Advisory Council or Board. The following will be considered in making funding decisions:
Relevance of the proposed project to program priorities.
Additionally, ICs may specify any special reporting requirements for the proposed clinical trial to be included under IC-specific terms and conditions in the NoA. For example: If the proposed clinical trial has elevated risks, ICs may require closer programmatic monitoring and it may be necessary to require the awardee to provide more frequent information and data as a term of the award (e.g., to clarify issues, address and evaluate concerns, provide documentation). All additional communications and information related to programmatic monitoring must be documented and incorporated into the official project file. Individual awards are based on the application submitted to, and as approved by, the NIH and are subject to the IC-specific terms and conditions identified in the NoA. ClinicalTrials.gov: If an award provides for one or more clinical trials. By law (Title VIII, Section 801 of Public Law 110-85), the "responsible party" must register and submit results information for certain "applicable clinical trials" on the ClinicalTrials.gov Protocol Registration and Results System Information Website (https://register.clinicaltrials.gov). NIH expects registration of all trials whether required under the law or not. For more information, see http://grants.nih.gov/ClinicalTrials_fdaaa/
Institutional Review Board or Independent Ethics Committee Approval: Grantee institutions must ensure that the application as well as all protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the awardee must provide NIH copies of documents related to all major changes in the status of ongoing protocols. Data and Safety Monitoring Requirements: The NIH policy for data and safety monitoring requires oversight and monitoring of all NIH-conducted or -supported human biomedical and behavioral intervention studies (clinical trials) to ensure the safety of participants and the validity and integrity of the data. Further information concerning these requirements is found at http://grants.nih.gov/grants/policy/hs/data_safety.htm and in the application instructions (SF424 (R&R) and PHS 398).
Investigational New Drug or Investigational Device Exemption Requirements: Consistent with federal regulations, clinical research projects involving the use of investigational therapeutics, vaccines, or other medical interventions (including licensed products and devices for a purpose other than that for which they were licensed) in humans under a research protocol must be performed under a Food and Drug Administration (FDA) investigational new drug (IND) or investigational device exemption (IDE).
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA. HHS provides general guidance to recipients of FFA on meeting their legal obligation to take reasonable steps to provide meaningful access to their programs by persons with limited English proficiency. Please see https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/index.html. The HHS Office for Civil Rights also provides guidance on complying with civil rights laws enforced by HHS. Please see http://www.hhs.gov/ocr/civilrights/understanding/section1557/index.html; and https://www.hhs.gov/civil-rights/for-providers/laws-regulations-guidance/index.html. Recipients of FFA also have specific legal obligations for serving qualified individuals with disabilities. Please see http://www.hhs.gov/ocr/civilrights/understanding/disability/index.html. Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697. Also note it is an HHS Departmental goal to ensure access to quality, culturally competent care, including long-term services and supports, for vulnerable populations. For further guidance on providing culturally and linguistically appropriate services, recipients should review the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care at http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53.
Cooperative Agreement Terms and Conditions of Award
When multiple years are involved, awardees will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the NIH Grants Policy Statement.
eRA Service Desk (Questions regarding ASSIST, eRA Commons registration, submitting and tracking an application, documenting system problems that threaten submission by the due date, post submission issues)
Grants.gov Customer Support (Questions regarding Grants.gov registration and submission, downloading forms and application packages)
GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
Dr. Rebekah Rasooly
Email: rebekah.rasooly@nih.gov
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Kelli Oster
Email: osterk@mail.nih.gov


I recently had a chance to review the new SnoreRx which has now replaced the original version after it was criticized for its incredibly large size. The redesigned version addresses the issue of being too bulky by reducing the overall size of the mouthpiece, especially in the molar area.
After making improvements to the original design, the manufacturer now claims to be the undisputed best-in-class stop snoring mouthpiece. Does it really stand up to these claims? I put the new SnoreRx to the test and documented the results along the way.
Fill a mug with boiling hot water. Carefully drop the device in and allow to rest for 90 seconds.
Remove the SnoreRx using a pair of tongs and give it a quick dip into a mug filled with cold water for 2-3 seconds.
Open wide and place the entire unit into your mouth with the "UPPER" marking facing up. Bite down and hold for 30 seconds.
Remove the mouthguard and immediately drop it into cold water. Leave for 60 seconds.
I found the fitting process to be rather simple, taking less than 5 minutes total. I was able to achieve a close fit on my first attempt. The instructions state that you can try up to 3 times if you don't have success the first time. Keep in mind that heating and cooling the device more than 3 times can weaken the material and render it useless.
Immediately after taking the impression I adjusted the setting to 5 mm before trying it out the first night.
I've been working the overnight shift lately so this gave my wife the perfect opportunity to observe my snoring habits. While asleep she checked in throughout the first night (her day) and did not hear a single sound. Instant success!
Upon rising, I noticed a bit of tenderness in my jaw from being stretched overnight. Before going to bed the following night, I reduced the advancement by 1 mm to 4 mm. This position felt more natural and comfortable. After another night of heavy sleeping, my wife reported absolutely no snoring sounds coming from the bedroom. In the morning my jaw was no longer tender and the snoring was gone.
I decided to test the device for an additional 6 nights and had experienced success night after night. Overall it was incredibly effective and comfortable to wear.
The SnoreRx is a MAD that actually allows advancement adjustment. Most devices move the jaw forward to a position that may or may not be comfortable or effective. This device allows forward adjustments up to 10mm which is nearly 1/2″. The manufacturer recommends that you begin using the device in the 4mm-5mm setting range before making any adjustments for a more comfortable fit.
In addition to the incremental forward adjustments feature, you are also able to create a custom mold that conforms to the shape of your teeth. The SnoreRx offers similar boil and bite technology commonly found with other oral appliances. Simply drop the device in boiling water for 60 seconds, remove and cool slightly then take an impression of the teeth by biting down. Have a bowl of ice water handy to drop it in once formed.
The newer SnoreRx features a thin inner frame that is both rigid and durable. The unique frame allows you to make small incremental tray adjustments by "ratcheting" it forward and back.
Longevity is also a selling feature that several companies rarely talk about. This product is created from a medical-grade copolymer, making it both durable and long lasting. They claim that one should expect for it to last anywhere from 12 to 15 months. Several similar products last less than a year and often only 4-6 months. Since some non-prescription MAD's are relatively expensive, this is an important factor that one should take into consideration.
Expect to pay a bit more for a product that offers so many features. The SnoreRx currently retails for $99.00 plus $6.95 for standard United States Postal Service shipping. Overall cost shipped to your door comes to around $106.00.
One consideration that should be examined when shopping around for a MAD is whether or not it's FDA cleared and BPA free.
Devices such as the SnoreRx are regulated by the Food and Drug Administration as a class II medical device. Prior to selling any such device, a manufacturer is required to obtain this FDA clearance. In doing so, the government is ensuring consumer safety. Keep in mind, not all products that are being sold in the United States are FDA cleared.
Also, some mouthpieces (often less expensive) may contain a controversial harmful toxic chemical known as BPA.
The manufacturer of the SnoreRx claims that their product is both FDA cleared and BPA free. After checking the FDA database, I was able to confirm that it was cleared in Nov 2011 and is currently registered.
An overwhelming majority of people who have tried this product agree that it is comfortable and easy to use. Most experience immediate results and are happy with their purchase.
On the other hand, there are some complains that have also surfaced online. The most common complaint has to do with shipping and billing. In older online reviews predating 2015, some individuals with smaller mouths found it to be too large and difficult to keep in their mouth overnight although this complaint seems to have been resolved with the latest updated version that was released in 2015. Others have reported oral discomfort for the first 2-5 days of use. This is typical of most devices and should eventually disappear.
Should I buy SnoreRx or try something else?
There is no doubt that this stop snoring device is well designed and functional but does this mean you should hand over the $106.00 and give it a try?
The SnoreRx is one of the few MAD's available without a prescription which allows you to adjust the position of your lower jaw. This combined with the custom boil and bite feature allows for a better fit when compared to other products on the market. Its design mimics oral appliances that are available from a dentist with a prescription. Most MAD's that are prescribed are used to treat obstructive sleep apnea and should not be confused with this product and other OTC stops snoring products.
As for the inventor and his credentials, there is very little information available. There are however several medical professionals who support this product which gives it credibility.
The price appears to be fair considering the complexity of its construction and its ability to last for a long time in comparison to other MAD's that are available.
I was very impressed with the quality and the ease of use. It's the only custom molded MAD on the market that can be adjusted over and over with no tools required. It's well constructed and should easily last the 12-15 months as recommended by the manufacturer.
After closely examining the SnoreRx myself and then comparing this information to what actual customers are saying, The SnoreRx receives my approval on the basis of comfort, adjustability, and durability.


text:
'Nah, I'll Pass!' 10 Celebrities Who Said No To Taking Pics With Fans Or Signing Autographs
by Sharon 26/11/2022
Many celebs look great and happy in the silly selfies they take with fans, so we often forget that they are human beings with their own life too. Over the years, fan selfies have turned from a great way of keeping memories to a way of getting attention on social media. This leads to a lot of privacy concerns and many other problems for these stars. No wonder why they stopped taking pics with fans or signing autographs!
Remember, you might feel like you know everything about your celebrity crushes, but they know nothing about you. They have every right to say no to taking pics with fans or signing autographs if the situations make them uncomfortable. Instead of a blurry photo, these celebs rather make their fans happy by other means. Let's find out how they do it.
1. Jennifer Lawrence
Jennifer Lawrence is one of the most down-to-earth and friendly celebrities ever, and for that reason, she often finds herself in trouble with her fans. The actress claimed that she was constantly approached for pictures and autographs and it made her very uncomfortable. Her job requires her to be under the spotlight most of the time. Saying no to taking pictures with fans is her way of keeping a level of privacy in her life as much as she can.
2. Billie Eilish
Billie Eilish won't sign autographs for a very particular reason: Her autographs will be sold online later. Many times after she signed autographs for fans, she would find them being sold online. She would rather hug and talk to her fans rather than sign something so they could sell it. The singer is happy to take selfies with fans though.
Emma Watson refused to take fan photos because she was concerned about her personal safety. "If someone takes a photograph of me and posts it, within 2 seconds they've created a marker of exactly where I am within 10 meters," she explained. However, Watson is very happy to talk with her fans and will talk with them as long as they want. Just don't photograph the encounter.
4. Chris Pratt
Chris Pratt doesn't like taking pictures with his fans, but that doesn't mean he hates running into them. The actor explained that he was okay with talking and shaking their hands. However, he felt like many people just took pictures with him to brag to their friends about it, and that didn't settle well with him. On many occasions, someone would quickly snap a photo even if has already declined.
5. Emily Blunt
Emily Blunt also shares the same reason as Chris Pratt. Blunt loves her fans' continuous support but she does not like being approached in public for a selfie, especially when she is with her children. However, the actress will be happy to offer a handshake and a hug if a fan approaches her.
Justin Bieber also refuses to take pictures with his fans. "I'm done taking pictures," he wrote on his Instagram post. The singer explains that he feels like a zoo animal and people don't even recognize him as a human. They won't say hi or ask him or anything. They just want a picture to say they have it.
7. Miley Cyrus
It's pretty shocking to hear this, but Miley Cyrus is actually camera-shy! She dislikes taking fan photos not because it's tiring, but because she finds it embarrassing. "I'm so embarrassed because people are taking pictures of me, and I just don't know how to smile and just be awkward, so I stick my tongue out, because I don't know what else to do," she explained.
8. Shailene Woodley
Shailene Woodley wishes people would respect each other's privacy more nowadays. She doesn't think random selfies without any specific memory attached to them can last long. The actress feels uncomfortable when people take their phones out on the street to take a picture with her.
9. Jonah Hill
Jonah Hill won't sign your autographs, but he will offer you his business cards. The card reads: "I just met Jonah Hill. It was a total letdown." Gotta admit it's a pretty funny way to say no to fan autographs. Apparently, he carries a bunch of the cards around every time he goes outside.
10. Russell Crowe
Russell Crowe is happy to spend time with his fans, just not when he is with his children though. At first, his son encouraged him to take pictures with fans so that they wouldn't get sad. However, the fans kept demanding more and more of Crowe's time and more pictures with him. "After two days, my little one said, 'I think you can stop that now, Dad," the actor recalled.
So those are the reasons why these celebrities say no to taking pics with fans or signing autographs. Their reasons are pretty solid, but some will say they're just arrogant. What is your opinion? Speaking of arrogant celebrities, there are some famous people who are just a total nightmare to work with. If you think these guys are arrogant, wait until you see these actors.

redpajama_set_name: RedPajamaCommonCrawl


text:
Need help gaining admittance? Hire a private college counselor
Author(s): Merry Mayer Date: November 11, 2003 Page: 12 Section: NEWS
College counselor Nancy G. Marcus of Winnetka has been advising students for 28 years. -Tom Cruze/Sun-Times
The numbers are scary. It is getting harder to gain admittance into the nation's more selective colleges.
In fact, 60 percent of colleges and universities have reported increases in applications in the last five years. The competition is stiffer. The number of students scoring 600 or better on the SAT has risen by 18 percent. Your high school counselor may not have the time to devote to you. While a 250-to-1 student-to-counselor ratio is recommended, the average Illinois high school counselor works with 700 students.
Before you tear your hair out, calm down. Remember your life will not be ruined if you don't get into your first-choice college.
Private college counselors will tell you all this. They will also tell you that you could benefit from their services.
Private college counseling is not new. Nancy G. Marcus of Winnetka has been in the business 28 years. "The appropriate reason to come to me is to make a good match," she said.
Her clients run the gamut. Some come from wealthy families, but she has two students this year whose fathers are out of work.
These services are also not just for those kids hoping to get into the Harvards and Yales. "I get underachievers and overachievers for the most part," said Susan J. Bigg, a certified educational planner in Lincoln Park.
Every year Marcus said she gets a few students who suddenly wonder, "Oh my God, who is going to take me (in their senior year). Some have good test scores but bad grades."
But senior year isn't when the planning should begin. If possible, a counselor can help sophomores and juniors choose activities that will make them stand out later when they are applying, said Chuck Hughes, founder and CFO of one of the newest entrants to the field, Road To College, based in Massachusetts.
"I'm not giving them a directive to do something that isn't them," he said. Instead, he shows them the things that, within the spectrum of their interests, will look best on a college application. Hughes comes from an insider point of view: For five years he was a senior admissions officer at Harvard College.
Road To College offers various packages so students can choose among the services based on what they want and what they can afford.
But generally most counselors help students find the right college for them, aid in the application process so that students are presented in the best possible light and then try to get them to relax a bit.
Your average high school counselor is good at helping with the college search, but not on the other side of the application, said Hughes.
Once a student decides where to apply, a private counselor may help the student come up with a good topic for the essay and then review the finished product.
"I will help them with it, but I am not going to polish it to perfection," Bigg said. "It has to be the voice of a 17-year-old and some colleges are getting wise to too-perfect essays."
All say they attempt to calm both students' and parents' fears. "The assumption is that if my child doesn't go to a certain school, their lives are forever circumscribed and that is not the case," said Marcus.
Merry Mayer
BITE OF WISDOM
SAT test takers in 2003, by ethnicity: 63.77% White; 0.71% American India/Alaskan Native; 3.72% other; 9.61% Asian or Pacific Islander; 10.23% Hispanic; 11.96% Black
Return to the
© Sun-Times News Group


EURU held a Chairman's Press Meeting on January 30, 2018.
Looking back at the results of imported vehicle sales last year, thanks to vigorous efforts of EURU members to introduce battery electric vehicles (BEV), plug-in hybrid electric vehicles (PHEV), clean diesel vehicles (CDV) and other next generation vehicles, as well as new models including SUV equipped with advanced safety features, connected technologies and the like, the imported vehicles had kept a high level of sales from the beginning of the year.
In 2018, EURU members will further launch new vehicles with diversified and upgraded power-train and introduce additional lineups of new models equipped with a wide-ranging advanced safety features, cutting-edge connected technologies and high-level automated driving-related technologies of higher levels, and the "Imported Automobile Market Outlook" for 2018 is steady growth.
While each EURU member is responsible for promoting sales of imported cars of their brands, EURU plans to further make requests for tax reform on behalf of the industry to ensure fair market conditions. In addition, we plan to continue carrying out EURU joint test ride to support EURU members.
On tax reform, while LDP Tax Research Council is expected to conduct its comprehensive examinations for reducing burdens on vehicle owners, EURU is convinced that the outcome of such comprehensive examinations will be vital for sustainable development of Japan's economy and the motor vehicle market in the future.
At the 38th Imported Car Joint Test Ride, 16 EURU members will offer 77 units of various new models from the European countries and the USA where automobile culture has been developed for many years. Not to mention BEV and PHEV, a lineup of the hottest models will include SUV and crossover models that meet the various lifestyles and needs of customers.
AEBS (Advanced Emergency Brake System), Full-Speed-Range ACC (Adaptive Cruise Control), LKA (Lane Keep Assist), LDW (Lane Departure Warning), Advanced Lighting Systems and Automatic Safety Belt Tightening will be showcased, in addition to wide-ranging safety features such as night vision, parking assist functions and rear collision warning systems. Cutting-edge connected technologies like 24/7 emergency reporting as well as high-level automated-driving technologies will also be presented. As this appropriately indicates, here I like to emphasize that EURU members will further introduce the models with diverse innovative technologies for safety and comfort in addition to better environmental and driving performance.
In November 2017, the UNECE World Forum for Harmonization of Vehicle Regulations (WP29) adopted UN Regulation R0 (ZERO), which prescribes procedures for IWVTA (International Whole Vehicle Type Approval). With UNR0 (ZERO) going into effect – although only partially – mutual recognition of type approvals is realized in principle for passenger cars. EURU highly appreciates the efforts of the officials of MLIT and other persons concerned. Hereafter, discussions will be conducted on IWVTA Phase 2, which will extend the range of technologies and devices covered, and EURU will be actively engaged in the efforts to achieve broader IWVTA.
Under the Preferential Handling Procedure (PHP) for Imported Motor Vehicles, in order to check the environmental performance of vehicles, it is required to conduct emission and noise tests based on a certain sampling rate per vehicle type. EURU welcomes the announcement made by the Government of Japan on November 6 in 2017 that Japan will streamline the procedures relating to noise and emission tests for the vehicles exported to Japan which are certified by PHP. We look forward to a quick start of such streamlining.
In addition, EURU welcomes harmonization of Japan's emission and fuel efficiency measurement procedures by starting to apply the World Light Vehicle Test Procedure (WLTP) from October of 2018. As soon as the application of WLTP starts, EURU will be able to make further contribution to sustainable mobility in Japan through the expansion of models launched in the country and early implementation of leading-edge technologies.
The diesel passenger car real driving emission (RDE) tests, to be introduced in Japan in October 2022, will be based on the EU RDE regulations which have already been introduced since September of 2017. EURU will continue consulting with MLIT to avoid additional excessive certification burdens on the importers.
With regard to fuel efficiency, the deliberations on the Post-2020 Fuel Efficiency (FE) Standards for Passenger Cars at the joint subcommittee meetings of METI & MLIT advisory councils will be conducted this year, and EURU will actively participate in the deliberations and express its position in a timely manner so as to ensure that the Post-2020 FE standards will be reasonable, well-balanced from the standpoint of technological developments and consumers' acceptance as well as fair to both imported and domestic automobile manufacturers.
First, I will present examples of progress in the activities for international harmonization of motorcycle-related standards and regulations. The Daytime Running Lamp (DRL) issue has remained in Japan; however, in June last year, the Japanese government submitted a proposal to the UN, which is expected to be, in due course, internationally agreed and then, implemented in Japan. EURU will further carry out activities for achieving international harmonization of motorcycle-related standards and regulations.
EURU has been conducting the Imported Motorcycle Test Ride since 2015. At the 3rd Imported Motorcycle Test Ride held in April last year, all ten EURU motorcycle members together provided 100 motorcycles for the test ride. Thanks to participation by representatives of 71 media, the "attractiveness of imported motorcycles had been spread widely through media coverage".
This year, the 4th EURU Imported Motorcycle Test Ride will be held at the Oiso Prince Hotel Long Beach on April 4th and 5th. We are now preparing to make sure that the 4th Motorcycle Test Ride will provide opportunities for riding a variety of latest models.
In addition, EURU will continue taking part in the Bike Love Forum (BLF), which was started in 2012 for the purpose of revitalizing Japan's motorcycle market.
This year, the 6th BLF meeting is planned to be held in Ichinoseki-city of Iwate-prefecture on a Friday in early August. Following the 6th BLF meeting, EURU, JAMA and other organizations concerned are now planning a project to let the participants fully enjoy the fun of riding motorcycles in areas hit by the Great East Japan Earthquake on March 11th in 2011 over that weekend, while at the same time supporting the reconstruction of these areas. Please do not miss this event.
In closing, EURU will further work to make sure that EURU members will be able to deliver to more customers in Japan those cars and motorcycles manufactured in various countries of the world that are equipped with advanced safety features, cutting-edge connected technologies and high-level automated driving technologies. We will also continue to carry out activities to create and maintain fair and free market conditions in cooperation with ACEA, JAMA and other automotive associations from home and abroad. Together with the Japanese government and related organizations, we aim at making further contributions to a sustainable development of Japan's motor vehicle market as a whole.


SKU: stnichsts001 SKU: stnichsts001 Categories: Authentic Antique Icons, Icons of the Saints, N, Other Iconographer. Tag: Nicholas the Wonderworker of Myra in Lycia.
St. Nicholas with seven additional saints – Early 19th / late 18th century icon on panel with double splines on reverse. Egg tempera over gesso grounds with kovcheg. Quality icon in very good condition. Russian. Size: 14″ x 18″ x 1.1″.


text:
Tapman Consulting & Resources, LLC. Privacy Policy
Last Updated on September 1st, 2021
At TapDanceMan.com.com& eTapDance.com (property of Tapman Consulting & Resources, LLC.):
We don't ask you for personal information unless we truly need it.
We don't share your personal information with anyone except to comply with the law, develop our products, or protect our rights.
We don't store personal information on our servers unless required for the on-going operation of our site.
Like most website operators, Tapman Consulting & Resources, LLC. collects non-personally-identifying information of the sort that web browsers and servers typically make available, such as the browser type, language preference, referring site, and the date and time of each visitor request. Tapman Consulting & Resources, LLC.'s purpose in collecting non-personally identifying information is to better understand how Tapman Consulting & Resources, LLC.'s visitors use its website. From time to time, Tapman Consulting & Resources, LLC. may release non-personally-identifying information in the aggregate, e.g., by publishing a report on trends in the usage of its website.
Tapman Consulting & Resources, LLC. also collects potentially personally-identifying information like Internet Protocol (IP) addresses for logged in users and for users leaving comments on our blogs. Tapman Consulting & Resources, LLC. only discloses logged in user and commenter IP addresses under the same circumstances that it uses and discloses personally-identifying information as described below, except that blog commenter IP addresses are visible and disclosed to the administrators of the blog where the comment was left.
Certain visitors to Tapman Consulting & Resources, LLC.'s websites choose to interact with Tapman Consulting & Resources, LLC. in ways that require Tapman Consulting & Resources, LLC. to gather personally-identifying information. The amount and type of information that Tapman Consulting & Resources, LLC. gathers depends on the nature of the interaction. For example, we ask visitors who comment on our blog to provide a username and email address. Those who wish to receive Terrence Taps' updates via email, we collect their emails. In each case, Tapman Consulting & Resources, LLC. collects such information only insofar as is necessary or appropriate to fulfill the purpose of the visitor's interaction with Tapman Consulting & Resources, LLC.. Tapman Consulting & Resources, LLC. does not disclose personally-identifying information other than as described below. And visitors can always refuse to supply personally-identifying information, with the caveat that it may prevent them from engaging in certain website-related activities.
Tapman Consulting & Resources, LLC. may collect statistics about the behavior of visitors to its websites. For instance, Tapman Consulting & Resources, LLC. may use spam screened by the Akismet service to help identify spam. Tapman Consulting & Resources, LLC. may display this information publicly or provide it to others. However, Tapman Consulting & Resources, LLC. does not disclose personally-identifying information other than as described below.
Tapman Consulting & Resources, LLC. discloses potentially personally-identifying and personally-identifying information only to those of its employees, contractors and affiliated organizations that (i) need to know that information in order to process it on Tapman Consulting & Resources, LLC.'s behalf or to provide services available at Tapman Consulting & Resources, LLC.'s websites, and (ii) that have agreed not to disclose it to others. Some of those employees, contractors and affiliated organizations may be located outside of your home country; by using Tapman Consulting & Resources, LLC.'s websites, you consent to the transfer of such information to them. Tapman Consulting & Resources, LLC. will not rent or sell potentially personally-identifying and personally-identifying information to anyone. Other than to its employees, contractors and affiliated organizations, as described above, Tapman Consulting & Resources, LLC. discloses potentially personally-identifying and personally-identifying information only in response to a subpoena, court order or other governmental request, or when Tapman Consulting & Resources, LLC. believes in good faith that disclosure is reasonably necessary to protect the property or rights of Tapman Consulting & Resources, LLC., third parties or the public at large. If you are a registered user of an Tapman Consulting & Resources, LLC. website and have supplied your email address, Tapman Consulting & Resources, LLC. may occasionally send you an email to tell you about new features, solicit your feedback, or just keep you up to date with what's going on with Tapman Consulting & Resources, LLC. and our products. We primarily use our various product blogs to communicate this type of information, so we expect to keep this type of email to a minimum. If you send us a request (for example via a support email or via one of our feedback mechanisms), we reserve the right to publish it in order to help us clarify or respond to your request or to help us support other users. Tapman Consulting & Resources, LLC. takes all measures reasonably necessary to protect against the unauthorized access, use, alteration or destruction of potentially personally-identifying and personally-identifying information.
A cookie is a string of information that a website stores on a visitor's computer, and that the visitor's browser provides to the website each time the visitor returns. Tapman Consulting & Resources, LLC. uses cookies to help Tapman Consulting & Resources, LLC. identify and track visitors, their usage of Tapman Consulting & Resources, LLC. website, and their website access preferences. Tapman Consulting & Resources, LLC. visitors who do not wish to have cookies placed on their computers should set their browsers to refuse cookies before using Tapman Consulting & Resources, LLC.'s websites, with the drawback that certain features of Tapman Consulting & Resources, LLC.'s websites may not function properly without the aid of cookies.
If Tapman Consulting & Resources, LLC., or substantially all of its assets were acquired, or in the unlikely event that Tapman Consulting & Resources, LLC. goes out of business or enters bankruptcy, user information would be one of the assets that is transferred or acquired by a third party. You acknowledge that such transfers may occur, and that any acquirer of Tapman Consulting & Resources, LLC. may continue to use your personal information as set forth in this policy.
Ads appearing on any of our websites may be delivered to users by advertising partners, who may set cookies. These cookies allow the ad server to recognize your computer each time they send you an online advertisement to compile information about you or others who use your computer. This information allows ad networks to, among other things, deliver targeted advertisements that they believe will be of most interest to you. This Privacy Policy covers the use of cookies by Tapman Consulting & Resources, LLC. and does not cover the use of cookies by any advertisers.
Comments and other content submitted to Akismet anti-spam service are not saved on our servers unless they were marked as false positives, in which case we store them long enough to use them to improve the service to avoid future false positives.
Although most changes are likely to be minor, Tapman Consulting & Resources, LLC. may change its Privacy Policy from time to time, and in Tapman Consulting & Resources, LLC.'s sole discretion. Tapman Consulting & Resources, LLC. encourages visitors to frequently check this page for any changes to its Privacy Policy. Your continued use of this site after any change in this Privacy Policy will constitute your acceptance of such change.
Terrence "Taps" Bennett
Founder of eTapDance.com
Copyright 2020 - Terrence Bennett, Tapman Consulting & Resources, LLC. - All Rights Reserved


Hi, I would like to request a test ride for the URBAN COMMUTER UCL-30 (If you have a preferred date and store location, please add it here).
Market leading technology with componentry that you'd expect to find on a much more expensive e-Bike. This model is an e-Bike that offers tremendous value for money for both the commuter or leisure cyclist. Eligible to purchase through the Government's Cycle to Work scheme the UCL-30 is the answer to traffic congestion and stressful commutes. This 'low step' frame makes it far easier to get on and off the bike, making it a great choice for commuters riding into work wearing their office clothes.
We are Eletric Bike Sales are fully dedicated to our customers. Not only do we provide diagnosis, repairs, and servicing, but we can also offer warranties, support plans, and trade-in options to help you get the most out of your investment. We also enjoy empowering our customers with as much information as possible. If you have any more questions, please feel free to Contact Us and we will reply as soon as possible! Thank you for viewing the URBAN COMMUTER UCL-30.


Plenty of natural light flow throughout the open and airy layout; stunning tile floors highlight stone accents and blend charmingly with the soft natural tones found through the home. This masterful design uniquely embodies both affordable luxury and sought-after modern features. If you're seeking to find the perfect patio home that is close to shopping, golf course, schools, and hospital, this home is calling your name. Beautiful courtyard entry with two bedroom, two baths plus office and 1649 sq ft.


Last week I decided that it was time for a change. Nothing drastic but a change nonetheless.
Well, I wanted to finally get to re-editing all my patterns and putting them in my new fancy layout. Which everyone seems to really love.
You see, when I was a fresh designer on the scene, I didn't know what a technical editor or graphic designer was. Nor did I know how important they were.
That means I have a whole bunch of patterns to work my way through. I've made it through two – of the over 250 designs I currently have published. The goal – one a day. For the next year. Beginning with my oldest and working my way up to the most recent.
I'm really hoping all of you love the new changes you'll see from Rohn Strong Designs in the coming months.
Now, I'm off to crochet!
I have been doing that this year too same reason.


With so many medical tests and treatments and so much scientific and medical information—some of it contradictory—how can people make the best medical decisions?
Most medical decisions, it turns out, are based on common sense. In this short and easy-to-read book, Dr. Phillip K. Peterson explains the ten rules of internal medicine. Using real case examples he shows how following the rules will help consumers make good decisions about their medical care.
Get Inside Your Doctor's Head providesadvice about such questions as when to seek treatment, when to get another opinion, and when to let time take its course. Turn to the Ten Rules when you are weighing your doctor's recommendations about diagnostic tests and treatments and use them to communicate more effectively with your doctor. As with all rules, the Ten Rules of Internal Medicine have occasional exceptions—and when evidence suggests that you are an exception, the relevant rule should be broken. Follow the Ten Rules to make decisions in the increasingly complicated medical world when you need guidance about health matters for yourself and your loved ones.


text:
We use cookies on your device to help make this site better. Some of the cookies are necessary for you to be able to use the full functionality of this site. We also use some cookies to collect information for making reports and to help us improve the site, and to track the effectiveness of our advertisements. The cookies on this site collect information in an anonymous form. For more information about how we use cookies please click here. By clicking 'Accept' you agree to recieve all cookies on this site. However, you can change your cookie settings in your browser at any time. accept & close
Why Choose Elephant & Castle
Elephant & Castle: a fun London district to live, visit, rent or buy in
The central London district is described as 'youthful and buzzy' due to the student vibe given by London College of Communication and London South Bank University. Alongside this, the article references the appeal of the area to young professionals.
Tom Crowe, lettings manager at Harrisons Property London says: "The recent Elephant Park development very much appeals to professionals in their 20s and 30s. Students from both London College of Communication and South Bank University further supplement tenant demand."
Based in Zone 1, Elephant and Castle has great travel links to the city via the Northern and Bakerloo Tube lines, and frequent train services to London Blackfriars (taking five minutes) and to London Waterloo East and London St Pancras International (around 15 minutes).
As well as a convenient base for city workers, Elephant and Castle offers a wide range of cultural and social experiences to enjoy.
The Homes & Property feature highlights The Cinema Museum as a key place to visit. This is housed in a Victorian workhouse where Charlie Chaplin lived as a child. It also shines a spotlight on Mercato Metropolitano, an exciting street food market and evening venue in Newington Causeway.
Known as the heartland of London's South American community, Elephant and Castle is home to a wealth of cafés and restaurants, including Colombian diner La Bodeguita, and a series of South American-inspired bars and eateries on Elephant Road.
As well as South American cuisine, Elephant and Castle is packed with other dining options. Highlighted spots include the Prince of Wales pub where locals play Pétanque in lovely Georgian Cleaver Square, and Toulouse Lautrec, a French brassiere and wine bar in Newington Butts that has received high recommendations.
The full article by Homes & Property can be found here.
https://www.homesandproperty.co.uk/property-news/renting/living-and-renting-in-elephant-castle-travel-links-parking-schools-best-streets-cost-of-monthly-rent-a130896.html
Our dedicated teams across all of our developments are here to help.
Lendlease named UK's most sustainable housebuilder in the NextGeneration Sustainability Benchmark
Glasshouse Gardens - one of the best places to live in London
Two new Show Apartments available in Elephant Park


Another fab and in-depth article from Craig Grannell on Digital Arts, this time on Web fonts: what designers need to know in 2015. Craig asked a load of smart designers (and me) about web fonts, web font services, and how to choose web fonts.
What do you consider the current best options for working with web fonts?
I'm forever changing my mind, but I tend to prefer to host fonts on the site itself. That way you usually have more control over the font itself, and you're not beholden to a font service that could slow your site down, or even go down completely. I also like paying a one-off fee for fonts where possible, even if it's a bit more expensive. A one-off fee is a more predictable cost than paying for a subscription for the foreseeable future.
For newcomers, what key differences are there in using a web font service of hosting fonts themselves?
When a web font service hosts the fonts themselves, it usually results in a great selection of typefaces for a very reasonable price. Most font services also handle a lot of the trickier technical stuff, so you can easily pick out the weights and subset you want, and you're good to go.
If you use a particular service, what differentiates it for you?
I always pick the service based on the typeface I want to use. When I'm designing the typography, I'll hunt down a few typefaces to choose from, then shop around a few services to see which gives me the most freedom and control at the most reasonable price.
The only service I always avoid is Google Web Fonts. When you install a script from a third party on your site, including web fonts, you need to trust that third party to deliver its goods, and only track the page data in a way that's appropriate to their services. Google makes money from tracking data, and is providing the font services for free. I wouldn't be happy exchanging the data of my visitors in return for free fonts. It's worth reading Yves Peters' post on about Google Web Fonts.
What changes in tech are likely during the first half of 2015, and how do you think this will benefit designers?
Whether its net neutrality, the snoopers charter, or rights to encryption, equal access and privacy keep coming up as primary concerns in tech. These important issues with rights and ethics on the web give designers great opportunities to create work that can make a difference to the future of our platform. With new problems, designers get the chance to work with new constraints and user experience challenges that could stand the test of time, rather than just making more commercial brochureware for a brand that'll disappear in a couple of years.
Categorised under: Design. Tagged with: Digital Arts magazine, font services, typography, web fonts.


Farjam has been a patent attorney for about 16 years. Before his law practice, Farjam was a professional engineer for 19 years in the fields of Computer Science and Electrical Engineering working mainly at Intel, IBM, and Microsoft.
Farjam has drafted over 400 patent applications and prosecuted many hundreds more before the USPTO in the arts of software, communications, electrical engineering, device physics, mobile devices, biomedical devices, mechanical engineering, structure/civil engineering, and others. Some of the patent applications were filed under PCT and prosecuted in foreign countries after National Phase entry. Farjam has also drafted appeal briefs, invalidity and non-infringement opinions, and patent valuation reports.


text:
Campus NewsHealthNews Releases
GRU to offer new doctoral degree in applied health sciences
Danielle Harris2 min readMarch 17, 2015
AUGUSTA, Ga. – The College of Allied Health Sciences at Georgia Regents University will offer a new doctoral degree in applied health sciences – the first program of its kind in the University System of Georgia.
"Applied health sciences is a vital source of new knowledge for today's society, and we are grateful to have the opportunity to produce professionals who will be able to discover new solutions to the health care needs of our communities," said Dr. Andrew Balas, Dean of College of Allied Health Sciences at GRU. "We are pleased to have in place faculty who are ready to lead the research and educational efforts to make this a successful doctoral program known for responding to real problems of practice."
This three-year, interdisciplinary doctoral program is designed to equip health professionals with the skills to solve health care issues in numerous fields of allied health. Graduates will be clinically oriented and prepared for roles in evidence-based practice or as faculty in allied health fields.
The coursework offers innovative and advanced research training in three concentration areas: rehabilitation science, health care outcomes, and diagnostic sciences.
Application deadline is May 31, 2015. For more information, call GRU's College of Allied Health Sciences at 706-721-2621 or visit gru.edu/alliedhealth.
Georgia Regents University is one of four public comprehensive research universities in the state with nearly 10,000 students enrolled in its nine colleges and schools, which include the Medical College of Georgia – the nation's 13th-oldest medical school – the nationally-ranked Hull College of Business and Georgia's only College of Dental Medicine. The clinical enterprise associated with the university includes the 478-bed Georgia Regents Medical Center and the 154-bed Children's Hospital of Georgia. GRU is a unit of the University System of Georgia and an equal opportunity institution. http://www.gru.edu
Tagged asAndrew BalasCollege of Allied Health SciencesDental College of GeorgiaJames M. Hull College of Business
Danielle Harris is Senior Media Relations Coordinator at Augusta University. Contact her to schedule an interview on this topic or with one of our experts at 706-721-7511 or deharris1@augusta.edu.
JagPulse will help Augusta University connect volunteers to the community
Miguelangelo Hernandez
Dental College of Georgia dean reflects on successful teaching, administrative career as she prepares for retirement
Augusta University posts second-highest enrollment growth among USG institutions for fall 2022
Milledge Austin
Physical therapy professor embodies 'pro bono publico' through service to community
Written by Danielle Harris
New doctoral degree in educational innovation will impact students, university, and community
Match Day set for March 20


text:
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">

<title>Overview List (grpc-core 0.1.0-SNAPSHOT API)</title>
<meta name="date" content="2015-03-22">
<link rel="stylesheet" type="text/css" href="stylesheet.css" title="Style">

All Classes

Packages

io.grpc

io.grpc.proto

io.grpc.transport

redpajama_set_name: RedPajamaGithub


text:
Exhibitions & Activities
The CCCB
The Casa de Caritat (Almshouse)
The CCCB is located in a spot with a long history: the site of a 12th century church that became the monastery of Montalegre in the 13th century and a Jesuit seminary in the 16th century. In the 18th century, a military barracks and correctional facility was installed there. Finally, in the year 1802, King Charles IV of Spain authorised the creation of a charitable establishment, the Casa de Caritat (Almshouse) to provide shelter for the most disadvantaged members of society. Over time, the Casa de Caritat came to fund itself and it obtained income from very diverse sources. It organised prize draws, masquerade balls, and bullfights. It also produced basic essentials: biscuits, needles, fabrics, noodles, rope sandals, cotton, clothing, et cetera. Its most profitable activities prominently included the municipal concession of the funeral service in 1838 and, especially, the creation of one of the city's most important printing presses. This self-funding system was achieved by the teaching of specialised trades (carpentry, blacksmithery, printing, shoemaking, etc.) within the Almshouse itself.
In the year 1868, responsibility for the establishment was transferred to the Provincial Council of Barcelona (Diputació), as a result of the Public Charity Law of 1853. In contrast, during the short period of the Republican Generalitat (1932-1936), the Casa de Caritat was the exclusive responsibility of the Catalan government; in that period significant improvements were made, especially in the treatment of inmates and the secularisation of the teaching staff. The Casa de Caritat ceased to function in the year 1957 with the move to and inauguration of new premises in the Vall d'Hebron district (Llars Mundet).
In 2016, the CCCB and the Xarxa Audiovisual Local (Diputació de Barcelona) in collaboration with BATABAT produce the documentary Temps de caritat. The film evokes the childhood of the people who lived in la Casa de la Caritat de Barcelona. Nowadays, they meet every Thursday at the CCCB bar.
The creation of the CCCB
In 1989, the Consortium formed by the Diputació de Barcelona and Ajuntament de Barcelona approved the creation of the CCCB, within the context of a project for the rehabilitation of the Raval neighbourhood and its historical buildings, and with the intention of housing a complex for contemporary culture in the former Casa de Caritat.
The Centre's management commissioned architects Helio Piñón and Albert Viaplana, with the collaboration of Eduard Mercader, with the construction project for the cultural facility. Building work began in 1991 and the CCCB was officially inaugurated on 24 February 1994 under the directorship of Josep Ramoneda, who was at the helm of the Centre from 1989 until 2011. This position was later held by Marçal Sintes (2011-2014) and Vicenç Villatoro (2014-2018). Judit Carrera has been the director of the centre since 1 October 2018.
The former Casa de Caritat premises occupied an enormous maze of constructions built in different eras, coming to house over two thousand people. Today the CCCB occupies the original structure of three wings arranged in a U-shape around a large central courtyard: the Pati de les Dones, and the building that housed the former theatre of the Casa de Caritat, on what is today the Plaça Joan Corominas.
The remodelling project began in the year 1991 and substituted the northern wing with a rectangular block measuring thirty metres high: a glass façade that has become a mirror of the urban landscape and a lookout point over the city. The external façade on Carrer de Montalegre and those of the courtyard, conserve the decoration of sgraffiti and majolica applications added in the years 1926-1929. As for the construction elements characteristic of the original buildings, also preserved are the brich vaults and the stone pillars. The building covers a total floor area of 15,000 m2 according to the project design implemented by architects Helio Piñón and Albert Viaplana, which was rewarded with the FAD and the Ciutat de Barcelona Architecture prizes in the year 1993.
In 2011, the CCCB incorporated a new building, the Teatre CCCB, the former Casa de Caritat theatre, refurbished by architects Elías Torres and Martínez Lapeña. With the Theatre, the CCCB gained a space measuring 3,164 m2 which gave the Centre improved functional conditions for implementing its programming. This new venue includes the Sala Teatre, a multi-purpose hall with an audience capacity of 500 people, and the Sala Raval, with capacity for 170 people.
This email address is incorrect
Become a Friend!
Touring activities
Work at the CCCB
The CCCB is a consortium formed by


text:
Q: How to export ArcGIS feature class to Waze? I've got a geodatabase containing a local municipality road system.
I'm looking for a way to export it into Waze in order to improve Waze existing road system.
The only way I found so far is to edit Waze road system manually, which can take quite a long time.
Is there any way doing so in a more straightforward way?

A: I think you are correct that the only way to update Waze is manually using the Waze Map Editor.
To determine whether there is any unadvertised means to apply updates in the way you seek I recommend contacting Waze using their Contact Us page.

A: You're correct that the only way to export this is through the editor, but the scripts that enable the editor are open to developers. You can add features programmatically using scripts via Tampermonkey and similar add-on script tools. That could add features automatically into the editor, but ultimately you're responsible for reviewing and saving your own work.
I've used it to add and manipulate house numbers, but theoretically it could be used for things like streets and places.
The big thing is you're limited to things you can do manually (you can't edit things above your editor level), as well as governed by limits (adding too many features too quickly can limit your credits). Also it's highly frowned upon (even well-intentioned scripts can have negative consequences), and so local managers may want a tight review of what you're doing. Doing so via the editor can give you a chance to review your edits and adds before committing, which can limit the harm runaway scripts can do.
Waze has a large and vibrant scripting community, and I highly recommend reaching out to them. I'm sure many have had similar ideas already and can get you started.
https://www.waze.com/forum/viewforum.php?f=819

A: Engage with Waze and sign up for the Citizen Partner Program.  Have seen agencies use FME or ArcGIS Open Data/GeoEvent to pass data over to Waze and also pull their information into your internal GIS.

redpajama_set_name: RedPajamaStackExchange


text:
Q: How do you _unset_ the default printer? I know I'm going to hit myself when someone tells me the answer, but I set the Default Printer on my Mac, and wish I hadn't.  Previously, it would default to the last printer used, which was great.  Now I can't find a way to unset the default printer to get back to the last printer used state.
FWIW, I'm on a Mac OS X 10.9.5 - Mavericks.
Command line solutions welcome too...

A: Go to System Preferences → Printers & Scanners and set Default printer to Last printer used.

A: I knew I would hit myself, but I Just found my answer.  It's right there in the preferences dialog near the bottom.  I was too focused on the list of printers on the left.  Will delete my own question in just a second.


Eileen Cook grew up in a small town in Michigan, but would go on to live in Boston and Belgium before settling in Vancouver, Canada with her husband and two very naughty dogs.
Eileen is a popular speaker at conferences both in the US and in Canada, provides writing/editorial coaching, and is a mentor/instructor for the Simon Fraser University The Writer's Studio.
I grew up as a book nerd. I made weekly trips to the library. I remember reading The Outsiders and anything that Judy Blume could write. I knew I wanted to be a writer, but I didn't set out to be a YA writer. My first book, UNPREDICTABLE, was an adult romantic comedy. One of my reviews commented that I had a great voice for YA. I hadn't read YA at that point since I was a YA so I marched off to the library and checked out a huge stack of books. I fell in love and haven't changed my focus since then.
They might be surprised to find out that I'm quite shy and introverted. I can pretend to be an extrovert for short periods of time. I've done presentations for up to 300 people at a time, but when it's all over I want to go home and hide under the bed for a few hours.
My parents have framed up a homework assignment I did in second grade. We were supposed to practice writing sentences, but I strung mine together to make a story. The teacher wrote: "I'm sure someday you'll be an author." Then I went through a long period where I started LOTS of books, but I didn't finish them. I would be excited in the beginning, but would then write myself in a corner and quit. About fifteen years ago I realized that I had to push through a finish an entire book to start getting better.
To read! I was lucky enough to have some great teachers that really encouraged a passion for books. I learned to try books that I might not automatically reach for and how to figure out what I liked or disliked about a book.
Did you learn anything from writing Used to Be and what was it?
USED TO BE is an interesting book because it was a chance to put two of my past books, GETTING REVENGE ON LAUREN WOOD and THE EDUCATION OF HAILEY KENDRICK together. I learn something with every book, either an odd piece of trivia (for example in writing Hailey I learned that more people are killed by falling vending machines than in shark attacks- who knew?) or something about myself. When writing Getting Revenge I explored if I thought revenge was worth it.
For those who are unfamiliar with Hailey, how would you introduce her?
Hailey's had a good life. She comes from a wealthy family, she dates an amazing guy and she's the top of her class. What she has to learn is how to deal with things when they don't go well.
What part of Lauren did you enjoy writing the most?
It's always fun to write "the bad girl." They have a chance to say and do all the things that I would never do.
If you could introduce Hailey to any character from another book, who would it be and why?
I'd love for Hailey to meet Hermione Granger from Harry Potter. I have the sense the two of them would get along. They're both whip smart and even they both plan to avoid trouble, but don't seem to be able to do it.
Oooh hard question. I've learned so much from so many writers I'm not sure I could pick just one. I'm always impressed with how generous most writers are. Writing is a hard profession. There's a lot of rejection and difficult days. Having someone who has been through the same experiences is a huge help.
It depends how you want to look at it. I have eight books that are published and one coming in December. I have another book that is done that I'm working with my editor on. Then there are the books I wrote before I was published while I was still learning. There are at least three full novels that have never seen the light of day that I consider my "practice" books.
Life doesn't give you a dress rehearsal. Read good books, travel, meet new people, try weird foods, don't be afraid to dance, spend time with your friends, and whatever you do- don't give up on your dreams.
Do bad reviews bother you? I always say: "No of course not. You can't please everyone." Truth is I obsess over them and wonder what I could have done differently. I'm better than I used to be, but it's still a work in progress to let go of worrying about what other people think.
I worked at Dairy Queen for one summer. The manager LOVED his job. He lived and breathed working at the DQ. He was always lecturing us on how to make the perfect circle on the top of the cone and how to get even sprinkle distribution. No one should take soft serve that seriously. He acted like we were working at the Pentagon keeping the world safe.
My husband's my best friend so he gets the honor of being the person I unload on when I've had a bad day. I'm also lucky to have a good group of friends I can call on when he's ready for a break.
I re-read John Green's The Fault in Our Stars and bawled like a baby just a few days ago. I also cry at ASPCA commercials, sad movies, and when the book I'm writing isn't going well and I want to beat my head on the desk.
Enjoy two wise and witty stories from Eileen Cook in one great book!
In The Education of Hailey Kendrick, Hailey is tired of always doing exactly what's expected of her. She's going to prove she's not perfect by breaking a very big rule in a very public way…with a very unexpected partner in crime. When Hailey gets caught, she loses everything—her best friend, her boyfriend, her popularity, her reputation. Now Hailey is up for anything…maybe even the boy she never noticed before. But even with her new bad girl image, she still has to ask herself: How far is too far?
In Getting Revenge on Lauren Wood, Lauren and Helen used to be best friends…until Lauren betrayed Helen in a manner so publicly humiliating that Helen had to move to a new town just to save face. Now Helen is back, and she's planning to bring down her former BFF by taking away everything that's ever been important to Lauren—starting with her boyfriend. Watch out, Lauren Wood. Things are about to get bitchy.
Eileen Cook's Used to Be is a compilation of two stories about growing up and moving on: Getting Revenge on Lauren Wood and The Education of Hailey Kendrick.
First, there are the two best friends, Lauren and Helen. After Lauren deceived Helen and publicly humiliated her, Helen moved out of town to escape the fiasco. Now that she has returned, only one thing is on her agenda...bring down her former BFF. She starts her revenge dinner so-to-speak with Lauren's boyfriend as her appetizer.
Second, we have Hailey, a girl who has always followed the rules and done what is expected of her with no question. She's tired of being labeled as perfect and sets to prove everyone wrong. Along with an accomplice, she publicly breaks a rule. After being caught, she literally loses everything but keeps it up to protect someone she ends up taking the blame for and deals with the consequences. But how long will she keep it up before it has gone too far?
Eileen has crafted two wonderful pieces of literary works that are fun and entertaining. Both stories had engaging dynamic characters. The writing style is absolutely amazing and provides readers with a clear understanding of the characters' personal viewpoints of their predicaments. The theme of friendship and revenge is carefully outlined as it focuses on the last stretch of a long-standing friendship and the very things humans will do when they feel they have been betrayed. Used to Be are stories that are familiar but are rarely done well. Eileen's careful mixture of drama and humor gracefully provides readers with a clear picture of the process of growing up and moving on. Just like her other books, it will not disappoint.
Thank you EILEEN COOK for making this giveaway possible.
1 Winner will receive a Copy of Used to Be by Eileen Cook.
Thank you so much for donating your book for this giveaway!!
I'm so excited for having the chance to win this book!! The interview went pretty well and is very enjoyable too.
Thanks for the chance to win this book, it sounds amazing!
Thank you Eileen for the donation and the giveaway! It sounds truly amazing!
Thanks so much Eileen! I've been wanting to read this one!


St. Peter's travels to Grace Lutheran Church in Lancaster the first Wednesday of each month to serve a community meal for those in need. Volunteers report to the church at 1:00 pm to prepare and cook the meal. They leave for Grace at 4:30 to set up and be ready to serve at 5:30 pm.
This is one of our outreach ministries that is supported financially by the church. About 10-15 volunteers help to shop, prepare, cook, and pack the food for travel. Volunteers are also responsible setting up the dining room, serving, washing dishes and packing up to return to church. We serve approximately 125 persons at each meal with more showing up in the winter months.
Our October 2018 meal was funded by Thrivent Choice Dollars. We are grateful for their partnership in helping to feed our neighbors. Anyone who has a Thrivent insurance policy, retirement account or other product is eligible for two $250 Thrivent Choice Dollars credit cards for outreach projects.


The implications of what 3D printing could help companies accomplish are huge. As industries from health care to auto manufacturing see possible benefits, though, companies also need to stay realistic about what they can accomplish in the near future. To that end, it may be wiser to focus on smaller, more feasible supply chain changes before 3D printing becomes more commonplace.
To be fair, this technology has already found a home in many sectors with high demand. Design News recently reported that 3D printing could expand as soon as next year, with organizations increasingly aware of the need for regulation and standards. The source said that 2017 could see more collaboration as different bodies band together to improve printing regulations.
Forecasting the future of 3D printing will be difficult without including the related term "additive manufacturing." This simply refers to the way material from a printer is injected to make whatever parts are required.
With flexibility a major concern, the ability to make items with custom details and based on specific plans could reduce the time processes take. Depending on what the printed objects are made of, the source said, suppliers may create parts that react to different environments, as well as models to help visualize changes. All of this points to the many ways this technology can disrupt normal business.
One example of 3D printing is in the medical prosthetic industry, where advances have already gained attention. Forbes recently spoke to startup Voodoo Manufacturing's co-founder Jonathan Schwartz, who highlighted some of the advantages of using 3D printing.
He said that 3D printing could grant companies the chance to produce on the most appropriate scale for each product. Voodoo specifically manufacturers prosthetic hands with 3D printers. In addition to making these aids more efficiently, these systems could also cut down on the gaps between locations and make it easier for businesses to hit their respective quotas, even if this doesn't comprise the entirety of production.
"It's something that speaks to the value of 3D printing versus other methods," Schwartz said. "It's currently cheaper to mass manufacture a standard but you can do sizes and replacement parts with 3D printing."
Following this logic, it's possible that the real benefits of this technology will be as a supplement to traditional systems before becoming the main source of components.
As always, it's important to think of the challenges 3D printing has to overcome to be a significant disruption. For one, there's the barrier keeping 3D printers from organic material, although this could already be shifting. Digital Trends reported on a German candy company that is developing sweets that can come from a 3D printer.
And while there's always room for future changes, the chief advantage of 3D printing could be its customization, not its efficiency. In a 2015 piece for Harvard Business Review, University of Oxford professor Matthias Holweg argued that 3D printing should be "a new tool in the box," not a complete replacement for the supply chain. He also stated that this system actually still requires labor, making it less simple than many may assume.
Because of this, businesses can invest in managed IT services as a whole to manage new resources and systems.
Do you have what it takes to be a consultant?
Is nearshoring growing in the US?
Welcome to 2017. No, 2016 Wasn't ALL Bad.


As already mentioned, JACK not only saves infant chimps but also takes care of bush babies or galagos.
In our Southern part of the DRC, one of the galago species we have is the biggest bush baby of Africa : the greater galago (otolemur crassicaudatus crassicaudatus).
Unlike apes and most of the DRC wildlife, these small nocturnal creatures are being poached for their meat. Pacific and the size of a cat, greater galagos are caught very easily: because they sleep in the trunk of the trees during day, poachers put the tree on fire and wait for the galagos to come out of their shelter.
Not many studies have been carried out on bush babies. Our project is receiving advice from the Nocturnal Primate Research Group coordinated by Professor Simon BEARDER, one of the world's leading authorities on nocturnal primates.